Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|---|
![]() |
![]() |
||||||||
GSM6034915 |
Feces of a patient affected by limited (ACA) sclerodermia [F_01_L]
|
SRA | 1 | Matteo Ramazzotti | Dec 28, 2023 | ||||
GSM6034916 |
Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_02_D]
|
SRA | 1 | Matteo Ramazzotti | Dec 28, 2023 | ||||
GSM6034917 |
Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_03_D]
|
SRA | 1 | Matteo Ramazzotti | Dec 28, 2023 | ||||
GSM6034918 |
Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_04_D]
|
SRA | 1 | Matteo Ramazzotti | Dec 28, 2023 | ||||
GSM6034919 |
Feces of a patient affected by limited (ACA) sclerodermia [F_05_L]
|
SRA | 1 | Matteo Ramazzotti | Dec 28, 2023 | ||||
GSM6034920 |
Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_06_D]
|
SRA | 1 | Matteo Ramazzotti | Dec 28, 2023 | ||||
GSM6034921 |
Feces of a patient affected by limited (ACA) sclerodermia [F_07_L]
|
SRA | 1 | Matteo Ramazzotti | Dec 28, 2023 | ||||
GSM6034922 |
Feces of a patient affected by limited (ACA) sclerodermia [F_08_L]
|
SRA | 1 | Matteo Ramazzotti | Dec 28, 2023 | ||||
GSM6034923 |
Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_09_D]
|
SRA | 1 | Matteo Ramazzotti | Dec 28, 2023 | ||||
GSM6034924 |
Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_10_D]
|
SRA | 1 | Matteo Ramazzotti | Dec 28, 2023 | ||||
GSM6034925 |
Feces of a patient affected by limited (ACA) sclerodermia [F_11_L]
|
SRA | 1 | Matteo Ramazzotti | Dec 28, 2023 | ||||
GSM6034926 |
Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_12_D]
|
SRA | 1 | Matteo Ramazzotti | Dec 28, 2023 | ||||
GSM6034927 |
Feces of a patient affected by limited (ACA) sclerodermia [F_13_L]
|
SRA | 1 | Matteo Ramazzotti | Dec 28, 2023 | ||||
GSM6034928 |
Feces of a patient affected by limited (ACA) sclerodermia [F_14_L]
|
SRA | 1 | Matteo Ramazzotti | Dec 28, 2023 | ||||
GSM6034929 |
Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_15_D]
|
SRA | 1 | Matteo Ramazzotti | Dec 28, 2023 | ||||
GSM6034930 |
Feces of a patient affected by limited (ACA) sclerodermia [F_16_L]
|
SRA | 1 | Matteo Ramazzotti | Dec 28, 2023 | ||||
GSM6034931 |
Feces of a patient affected by limited (ACA) sclerodermia [F_17_L]
|
SRA | 1 | Matteo Ramazzotti | Dec 28, 2023 | ||||
GSM6034932 |
Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_18_D]
|
SRA | 1 | Matteo Ramazzotti | Dec 28, 2023 | ||||
GSM6034933 |
Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_19_D]
|
SRA | 1 | Matteo Ramazzotti | Dec 28, 2023 | ||||
GSM6034934 |
Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_20_D]
|
SRA | 1 | Matteo Ramazzotti | Dec 28, 2023 |